ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD229 Antibody [HLy9.25] - Low endotoxin, Azide free (A86557)

Mouse monoclonal [HLy9.25] antibody to CD229 for Flow Cytometry, IP, WB, ICC and Functional Studies.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-CD229 Antibody [HLy9.25] - Low endotoxin, Azide free
Description
Mouse monoclonal [HLy9.25] antibody to CD229.
Specificity
This antibody recognizes CD229 / Ly9, a 100-120 kDa cell surface glycoprotein expressed on T and B cells.
Applications
Flow Cytometry, IP, WB, ICC, Functional Studies
Dilutions
FUNC: Regulation of activation, Flow Cytometry: 6-10 µg/ml; Positive Control: peripheral blood lymphocytes.
Reactivity
Human
Immunogen
CD299-transfected 300.19 pre-B cell line.
Host
Mouse
Clonality
Monoclonal
Clone ID
HLy9.25
Isotype
IgG1
Conjugate

Unconjugated

Purification
Protein A chromatography.
Concentration
1 mg/ml
Predicted MW
100-120 kDa
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, without Sodium Azide (0.2 µm filter sterilized). Endotoxin level is less than 0.01 EU/µg of the protein.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Synonyms
Cell surface molecule Ly-9, LY9, Lymphocyte antigen 9, Signaling lymphocytic activation molecule 3, SLAM family member 3, SLAMF3, T-lymphocyte surface antigen Ly-9
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD229 Antibody [HLy9.25] - Low endotoxin, Azide free (A86557)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD229 Antibody [HLy9.25] - Low endotoxin, Azide free (A86557)

Proteins predicted to interact with CD229

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98% Relevancy Score
94.8% Relevancy Score
93.9% Relevancy Score
80.6% Relevancy Score
76.4% Relevancy Score
70.6% Relevancy Score
68.6% Relevancy Score
67.4% Relevancy Score
61.1% Relevancy Score